- Home
- CNVS vs ADAG Comparison
CNVS vs ADAG Comparison
Compare CNVS & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNVS
- ADAG
- Stock Information
- Founded
- CNVS 2000
- ADAG 2011
- Country
- CNVS United States
- ADAG China
- Employees
- CNVS 218
- ADAG N/A
- Industry
- CNVS Consumer Electronics/Video Chains
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- CNVS Consumer Discretionary
- ADAG Health Care
- Exchange
- CNVS Nasdaq
- ADAG Nasdaq
- Market Cap
- CNVS 102.4M
- ADAG 90.8M
- IPO Year
- CNVS 2003
- ADAG 2021
- Fundamental
- Price
- CNVS $5.37
- ADAG $2.39
- Analyst Decision
- CNVS Buy
- ADAG Strong Buy
- Analyst Count
- CNVS 1
- ADAG 2
- Target Price
- CNVS $10.00
- ADAG $7.00
- AVG Volume (30 Days)
- CNVS 319.1K
- ADAG 105.9K
- Earning Date
- CNVS 08-14-2025
- ADAG 08-12-2025
- Dividend Yield
- CNVS N/A
- ADAG N/A
- EPS Growth
- CNVS N/A
- ADAG N/A
- EPS
- CNVS 0.13
- ADAG N/A
- Revenue
- CNVS $80,173,000.00
- ADAG $103,204.00
- Revenue This Year
- CNVS N/A
- ADAG $9,789.15
- Revenue Next Year
- CNVS N/A
- ADAG $29.92
- P/E Ratio
- CNVS $40.21
- ADAG N/A
- Revenue Growth
- CNVS 77.07
- ADAG N/A
- 52 Week Low
- CNVS $0.72
- ADAG $1.33
- 52 Week High
- CNVS $7.39
- ADAG $3.58
- Technical
- Relative Strength Index (RSI)
- CNVS 49.97
- ADAG 59.95
- Support Level
- CNVS $4.62
- ADAG $1.65
- Resistance Level
- CNVS $5.08
- ADAG $2.50
- Average True Range (ATR)
- CNVS 0.45
- ADAG 0.37
- MACD
- CNVS -0.08
- ADAG 0.03
- Stochastic Oscillator
- CNVS 54.64
- ADAG 77.89
About CNVS Cineverse Corp.
Cineverse Corp is a main streaming technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, Podcast and other, and Other non-recurring.
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.